Protein Science
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print January 24, 2008
Protein Science, DOI: 10.1110/ps.073277108
Copyright © 2008 The Protein Society
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Research Data
Right arrow All Versions of this Article:
ps.073277108v1
17/3/563    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodríguez-Zavala, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodríguez-Zavala, J. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Enhancement of coenzyme binding by a single point mutation at the coenzyme binding domain of E. coli lactaldehyde dehydrogenase

José Salud Rodríguez-Zavala

Departamento de Bioquímica, Instituto Nacional de Cardiología "Ignacio Chávez," Tlalpan D.F. 14080, Mexico

(RECEIVED October 3, 2007; FINAL REVISION November 20, 2007; ACCEPTED November 20, 2007)

Phenylacetaldehyde dehydrogenase (PAD) and lactaldehyde dehydrogenase (ALD) share some structural and kinetic properties. One difference is that PAD can use NAD+ and NADP+, whereas ALD only uses NAD+. An acidic residue has been involved in the exclusion of NADP+ from the active site in pyridine nucleotide-dependent dehydrogenases. However, other factors may participate in NADP+ exclusion. In the present work, analysis of the sequence of the region involved in coenzyme binding showed that residue F180 of ALD might participate in coenzyme specificity. Interestingly, F180T mutation rendered an enzyme (ALD-F180T) with the ability to use NADP+. This enzyme showed an activity of 0.87 µmol/(min * mg) and Km for NADP+ of 78 µM. Furthermore, ALD-F180T exhibited a 16-fold increase in the Vm /Km ratio with NAD+ as the coenzyme, from 12.8 to 211. This increase in catalytic efficiency was due to a diminution in Km for NAD+ from 47 to 7 µM and a higher Vm from 0.51 to 1.48 µmol/(min * mg). In addition, an increased Kd for NADH from 175 (wild-type) to 460 µM (mutant) indicates a faster product release and possibly a change in the rate-limiting step. For wild-type ALD it is described that the rate-limiting step is shared between deacylation and coenzyme dissociation. In contrast, in the present report the rate-limiting step in ALD-F180T was determined to be exclusively deacylation. In conclusion, residue F180 participates in the exclusion of NADP+ from the coenzyme binding site and disturbs the binding of NAD+.

Keywords: ALDHs; aldehyde dehydrogenases; ALD; lactaldehyde dehydrogenase; catalytic efficiency; burst; coenzyme binding domain


Supplemental material: see www.proteinscience.org

Reprint requests to: José Salud Rodríguez-Zavala, Departamento de Bioquímica, Instituto Nacional de Cardiología, Tlalpan, México D.F. 14080, Mexico; e-mail: rodjos{at}cardiologia.org.mx; fax: 52 55 55 73 09 26.

Abbreviations: ALDHs, aldehyde dehydrogenases; ALD, lactaldehyde dehydrogenase; PAD, phenylacetaldehyde dehydrogenase; Vh-ALDH, Vibrio harveyi aldehyde dehydrogenase; ALDH1, class 1 aldehyde dehydrogenase; ALDH3, class 3 aldehyde dehydrogenase.

Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.073277108.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by The Protein Society.